Is sarcosine a biomarker for prostate cancer?
Sarcosine was suggested in a letter to Nature in 2009 as a biomarker for prostate cancer. This communication reviews what has been accomplished to date to determine whether sarcosine is or is not a biomarker for prostate cancer that can replace prostate-specific antigen tests.
Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD 21702, USA. issaqh@mail.nih.gov
Haleem J
HJ
Issaq
Timothy D
TD
Veenstra
D014408:Biomarkers, Tumor / Q000032:analysis* / Q000378:metabolism; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000378:metabolism*; D012521:Sarcosine / Q000032:analysis* / Q000378:metabolism
D014408:Biomarkers, Tumor; D012521:Sarcosine